Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Individualized treatment improves symptoms and quality of life for women with PCOS.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Some common medications can harm male fertility, but many effects can be reversed.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

New treatments aim to improve thin endometrium to help more couples with infertility.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Anabolic steroid users may face higher risk of severe COVID-19.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

PRP therapy may help with ovarian issues and fertility, but more research is needed.